Pharma Tech Outlook recently featured Taconic Biosciences as a top microbiome solutions provider in 2020. Dr. Alexander Maue, a Scientific Program Manager at Taconic with extensive experience in immunology and germ-free mice, was featured in this article to comment on evolving research into the microbiome of mouse models. He specifically highlights the growing microbiota repository, which enables researchers to select a specific microbiome for association with their research models:
"Today, owing to the continuous technological advancements and the resulting reduction in the cost of analysis, microbiome research, which focuses on the behavior, interactions, and function of microbial communities, has significantly evolved over the last decade. In light of this development, microbiome researchers can now better under the applications of their findings in the realms of drug discovery and biopharmaceutics. As a result, many organizations in the pharma world are becoming increasingly aware how the microbiome may impact all in vivo models irrespective of therapeutic area, which is driving the establishment of a dedicated microbiome research arm."
Read more at: microbiome.pharmatechoutlook.com
"Today, owing to the continuous technological advancements and the resulting reduction in the cost of analysis, microbiome research, which focuses on the behavior, interactions, and function of microbial communities, has significantly evolved over the last decade. In light of this development, microbiome researchers can now better under the applications of their findings in the realms of drug discovery and biopharmaceutics. As a result, many organizations in the pharma world are becoming increasingly aware how the microbiome may impact all in vivo models irrespective of therapeutic area, which is driving the establishment of a dedicated microbiome research arm."